Compare ALVO & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | AI |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | Luxembourg | United States |
| Employees | 1460 | 1181 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2020 |
| Metric | ALVO | AI |
|---|---|---|
| Price | $3.25 | $8.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 14 |
| Target Price | $8.00 | ★ $14.00 |
| AVG Volume (30 Days) | 384.9K | ★ 4.0M |
| Earning Date | 05-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $389,056,000.00 |
| Revenue This Year | $13.28 | N/A |
| Revenue Next Year | $18.63 | N/A |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | N/A | ★ 25.27 |
| 52 Week Low | $3.03 | $7.68 |
| 52 Week High | $11.85 | $30.24 |
| Indicator | ALVO | AI |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 45.08 |
| Support Level | $3.10 | $8.45 |
| Resistance Level | $3.83 | $9.79 |
| Average True Range (ATR) | 0.20 | 0.44 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 13.27 | 28.43 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.